Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

AbbVie Inc.

NYSE: ABBV · Life Sciences · 5 alerts · CIK 1551152

Share price
$294.55Close, Nov 16
Market cap
$521B
Shares outstanding
1.77BLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All AbbVie Inc. filings on SEC EDGAR ↗

7:52 AM ET 8-K
Financial Results

AbbVie Financial Results

AbbVie reported third-quarter 2026 net revenues of $17.404 billion, a 10.3% increase driven by strong growth in its immunology and neuroscience portfolios. The company raised its full-year 2026 adjusted EPS guidance and announced a 5.2% increase to its quarterly dividend starting in February 2027.

Term
Q3 2026

“AbbVie continues to deliver outstanding results, reflecting solid execution across our diverse portfolio. We also enhanced our long-term growth potential by securing key regulatory approvals, generating differentiated clinical data and completing the acquisition of Apogee Therapeutics. Given our strong outlook and significant momentum, we are once again increasing AbbVie's full-year guidance and raising our quarterly dividend.”

Robert A. Michael, chairman and chief executive officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.